The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

(2009) C. A. London et al.   CLINICAL CANCER RESEARCH

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

(2009) Melissa C. Paoloni et al.   PLoS One

Phase 0 Clinical Trials: Conceptions and Misconceptions

(2008) Shivaani Kummar et al.   CANCER JOURNAL

Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship

(2008) Matthew Breen et al.   CHROMOSOME RESEARCH

Lost in translation: Problems and pitfalls in translating laboratory observations to clinical utility

(2008) Richard Simon   EUROPEAN JOURNAL OF CANCER

Feasibility and Safety of Targeted Cisplatin Delivery to a Select Lung Lobe in Dogs via the AeroProbe® Intracorporeal Nebulization Catheter

(2008) Kim Selting et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

(2008) Paul A. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY